GlassScriptPhysician profile
Benjamin Paul Boudreaux
NPI 1871723411
$9,431.72
in general payments reported to CMS, 2019-2025
33 companies · $975 in 2025
The $975 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $525 · 2020: $187 · 2021: $604 · 2022: $2,445 · 2023: $3,794 · 2024: $902 · 2025: $975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,106 · Travel and Lodging: $1,565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,105.62 |
| Travel and Lodging | $1,565.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,145.90 | 2021-2025 | Mazor X System, Pivox Oblique Lateral Spinal System, Medtronic Reusable Instruments |
| Boston Scientific Corporation | $2,554.04 | 2021-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Globus Medical, INC. | $1,412.11 | 2021-2024 | Rise-L . Rise-L A/L, Creo Mis Stabilization System, Mars Anterior Retractor |
| Stryker Corporation | $845.58 | 2023 | Everest Spinal System |
| Tepha INC | $205.46 | 2019 | |
| Nuvasive, INC. | $117.95 | 2022-2023 | Alif, Tlif |
| Alexion Pharmaceuticals, INC. | $114.74 | 2019-2020 | |
| Nevro Corp. | $109.89 | 2021 | |
| Baxter Healthcare | $109.61 | 2021 | |
| Arbor Pharmaceuticals, INC. | $100.00 | 2022 | |
| Providence Medical Technology, INC. | $98.58 | 2020-2023 | |
| Depuy Synthes Sales INC. | $76.41 | 2021-2023 | Symphony, Viper |
| Si-Bone, INC. | $57.37 | 2019 | |
| Aesculap, INC. | $53.64 | 2021-2022 | |
| Medtronic USA, INC. | $45.90 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 7d Surgical Ulc | $33.56 | 2021 | |
| Neurocrine Biosciences, INC. | $32.32 | 2019 | |
| Amgen INC. | $31.65 | 2019-2020 | |
| Integrity Implants INC. | $29.42 | 2021 | |
| Livanova USA, INC. | $28.90 | 2019-2021 | |
| Spineology INC. | $28.26 | 2022 | |
| Emd Serono, INC. | $26.02 | 2019-2020 | |
| Acorda Therapeutics, INC | $23.50 | 2019 | |
| Lemaitre Vascular, INC. | $18.98 | 2019 | |
| Nalu Medical, INC. | $17.34 | 2022 | |
| Lundbeck LLC | $16.73 | 2020 | |
| Tanabe Pharma America, INC. | $16.49 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $15.75 | 2019 | |
| Integra Lifesciences Corporation | $14.77 | 2021 | |
| Abbott Laboratories | $14.45 | 2021 | |
| Intrinsic Therapeutics | $14.16 | 2022 | |
| Adamas Pharmaceuticals, INC. | $11.39 | 2019 | |
| Zyla Life Sciences, INC. | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Boudreaux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.